Quick answers
- What is Galantamine used for?
- The FDA-approved label (Galantamine, Bryant Ranch Prepack, July 2, 2026) says: “Galantamine tablets are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. Galantamine tablets are a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Galantamine have a boxed warning?
- No. None of the 17 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Galantamine?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Galantamine been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Galantamine?
- 9 companies list prescription products of Galantamine in the FDA NDC Directory, including Bryant Ranch Prepack, Aurobindo Pharma Limited and Rising Pharma Holdings, Inc..
What Galantamine is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Galantamine tablets are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. Galantamine tablets are a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type
— FDA label: Galantamine, Bryant Ranch Prepack, effective July 2, 2026. Read the full label on DailyMed →
The FDA has 17 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 17 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet, film coated · Capsule, extended release · Solution |
|---|---|
| Route | Oral |
| Prescription products | 31 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| galantamine hydrobromide 12 mg tablet, film coated | Generic | $0.5038 per tablet |
| galantamine hydrobromide 16 mg capsule, extended release | Generic | $0.8928 per capsule |
| galantamine hydrobromide 24 mg capsule, extended release | Generic | $0.8856 per capsule |
| galantamine hydrobromide 4 mg tablet, film coated | Generic | $0.2704 per tablet |
| galantamine hydrobromide 8 mg capsule, extended release | Generic | $0.8262 per capsule |
| galantamine hydrobromide 8 mg tablet, film coated | Generic | $0.3941 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack8 products
- Aurobindo Pharma Limited6 products
- Rising Pharma Holdings, Inc.3 products
- Slate Run Pharmaceuticals, LLC3 products
- Sun Pharmaceutical Industries, Inc.3 products
- Upsher-Smith Laboratories, LLC3 products
- Golden State Medical Supply, Inc.3 products
- Hikma Pharmaceuticals USA Inc.1 product
- American Health Packaging1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (5)
- ANDA078185Hikma · January 30, 2009
- ANDA077604Yabao Pharm · February 6, 2009
- ANDA090178Sun Pharm · February 2, 2011
- ANDA090957Aurobindo Pharma Ltd · March 29, 2011
- ANDA204895Aurobindo Pharma · August 5, 2016
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Galantamine, Bryant Ranch Prepack, effective July 2, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →